Cheng Chig Fung 4

What Happened

• Cheng Chig Fung, Acting CEO & CFO and a Director of HUTCHMED (HCM), was allocated two blocks of LTIP ordinary shares on 2026-05-20: 30,157 shares and 26,307 shares (total 56,464). Each allocation is recorded at a purchase price of $0 on the Form 4 (derivative/other acquisition code J).
• These allocations reflect achievement of FY2025 performance conditions tied to prior LTIP awards (grants dated Aug 5, 2024 and Jun 9, 2025). The allocated shares are held by the LTIP trustee on his behalf and are expected to vest and be transferred to his personal account in 2027 and 2028, per the filing footnotes.

Key Details

• Transaction date: 2026-05-20; Form 4 filed: 2026-05-21.
• Price: $0.00 per share; reported transaction value $0 (allocation of awards, not an open-market purchase).
• Shares allocated: 30,157 (from 8/5/2024 LTIP grant) and 26,307 (from 6/9/2025 LTIP grant); total 56,464.
• Shares owned after transaction: Not specified in the information provided in this summary (check the full Form 4 for post-transaction holdings).
• Footnotes: F1/F2 confirm allocations were made because FY2025 performance conditions were met; shares are held by the LTIP trustee and are subject to future vesting/transfer (2027 and 2028).
• Timeliness: Filing was submitted the day after the transactions; no late filing indicated.

Context

• This was an award/allocation under the company’s Long Term Incentive Plan, not an open-market buy or sale. Allocations at $0 reflect performance-based awards being allocated, but the shares remain subject to the plan’s vesting and transfer rules and are held in trust until vesting — so they do not imply immediate sale or purchase activity in the market.
• For retail investors: such awards are common executive compensation when performance goals are met; they show the company met certain targets but do not by themselves indicate the insider’s near-term trading intent.